Introduction: Among the medical and surgical options which have been proposed in the last years for the management of male stress urinary incontinence (SUI), stem cell therapy represents a new frontier treatment.
The aim of this paper is to update the current status of stem cell therapy in animal and human studies for the management of iatrogenic male SUI.
Material and Methods: A PubMed review of the literature on stem cell therapy for the treatment of male SUI was performed.
Results: Regarding animal studies, bone marrow-, muscle- and adipose-derived stem cells have been widely studied, showing regeneration of the urethral sphincter and recovery of the damaged pelvic nerves. With regard to human studies, only four papers are available in the literature using muscle- and adipose-derived stem cells which reported a significant improvement in sphincteric function and incontinence with no severe side effects.
Conclusions: In spite of these promising results, further studies are needed with longer follow-ups and larger numbers of patients in order to clarify the potential role of stem cell therapy for the treatment of male SUI.
Written by:
Giberti C, Gallo F, Schenone M, Cortese P, Ninotta G. Are you the author?
Department of Surgery, Division of Urology, San Paolo Hospital, Savona, Italy.
Reference: Urol Int. 2012 Dec 5. Epub ahead of print.
doi: 10.1159/000342415
PubMed Abstract
PMID: 23221307
UroToday.com Stress Urinary Incontinence Section
